HDHeinrich Dickel

Heinrich Dickel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Heinrich Dickel has a total of 388 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Selective Goat's and Sheep's Milk Allergy With Occupational Contact Urticaria and Food‐Induced Anaphylaxis in a Chef

    by Tatjana Steen, Claudia Schröder‐Kraft, Ellen Rose, Christoph Skudlik, Heinrich Dickel

  • Open Access

    Patch Test Results With Additions to the European Baseline Series, 2021/22—Joint European Results of the ESSCA A and the EBS B Working Groups of the ESCD , and the GEIDAC C

    by Wolfgang Uter, S. Mark Wilkinson, Andrea Bauer, Leopoldo Borrego, Richard Brans, Timo Buhl, Heinrich Dickel, Rosella Gallo, Ana Giménez Arnau, Margarida Gonçalo, et al.

    Background: Allergens are periodically added to the European Baseline Series (EBS) to audit their value in consecutive patch testing. Objectives: To present results of audit allergens tested in consecutive patients in 54 departments in 13 European countries during 2021 and 2022. Methods: Anonymized or pseudonymized individual data, and partly aggregated data on patch test rest results and their clinical relevance were prospectively collected and centrally pooled and analyzed. Results: In 2021 and 2022, 18 832 patients were patch tested with the EBS, and 2860 with the TRUE Test baseline series (supplemented with some missing EBS allergens). Of these patients, 17 359 were additionally tested with one or more of the 19 audit allergen preparations examined. Apart from the terpene hydroperoxides (OOH) which yielded the highest numbers of positive patch test reactions (linalool‐OOH 1% pet.: 7.65 (7.09%–8.23%) [95% CI] and limonene‐OOH 0.3% pet. 6.78 (6.26%–7.32%)), positive reactions were most often seen to benzisothiazolinone (3.71 (3.3%–4.15%)), sodium metabisulfite (3.49 (3.14%–3.88%)), Evernia furfuracea (tree moss, 1.79 (1.4%–2.26%)), and decyl and lauryl glucoside, at 1.49 (1.25%–1.76%) and 1.26 (1.05%–1.51%), respectively. The other allergens yielded around 1% or fewer positive patch test reactions. Clinical relevance varied, with Evernia furfuracea , 2‐bromo‐2‐nitropropane‐1,3‐diol and terpene hydroperoxides considered relevant in more than 2/3 cases, while for other frequent sensitizers benzisothiazolinone and sodium metabisulfite, relevance could be confirmed in half of the cases or less often. Conclusions: The current results, along with other published data, will serve to inform decisions concerning possible revision of the EBS, considering frequency of positive reactions, their clinical relevance and the overall reaction profile of each of the allergens.


  • Open Access

    Patch Test Results With the European Baseline Series, 2021/2022—Joint European Results of the ESSCA A and the EBS B Working Groups of the ESCD , and the GEIDAC C

    by Wolfgang Uter, S. Mark Wilkinson, Olivier Aerts, Andrea Bauer, Leopoldo Borrego, Richard Brans, Timo Buhl, Heinrich Dickel, Aleksandra Dugonik, Francesca Larese Filon, et al.

    Background: Patch test results obtained with the European Baseline Series (EBS) in its current version serve both contact allergy surveillance and (re‐)assessing the diagnostic value of EBS allergens. Objectives: To present results of current EBS patch testing, obtained in 59 departments in 14 European countries during 2021 and 2022. Methods: Anonymised or pseudonymised individual data, and partly aggregated results, on demographic/clinical characteristics and patch test results with the EBS were prospectively collected, centrally pooled, and retrospectively analysed. Results: In 2021 and 2022, 18 832 patients were patch tested with the EBS. Sensitization to nickel remained most common (18.85 (18.29–19.43)% positivity (95% confidence interval)). Fragrance mix I and Myroxylon pereirae resin yielded very similar results with 6.39 (6.04–6.76)% and 6.5 (6.15–6.87)% positivity, respectively. Concerning preservatives, methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) 0.02% aq. yielded 5.52 (5.11–5.96)% and MI 0.2% aq. yielded 5.28 (4.94–5.64)% positives. Testing formaldehyde 2% aq. identified almost one percentage point more positive reactions than 1% aq. (2.05 (1.81–2.32)% vs. 1.22 (0.99–1.48)). Positive reactions to the recently added allergens were most frequently seen to propolis (5.47 (5.12–5.84)%) and 2‐hydroxyethyl methacrylate (3.63 (3.32–3.96)%). Conclusions: Compared to the previous reporting period, surveillance results with the EBS were mostly stable. The results regarding Quaternium 15 (0.4 (0.29–0.53)% positives) justified its exclusion from the 2023 EBS version.


  • Response to “A Slippery Slope: Is Benzyl Alcohol a Contact Allergen?”

    by Steffen Schubert, Barbara Ballmer‐Weber, Timo Buhl, Juliane Rieker‐Schwienbacher, Heinrich Dickel, Christian Apfelbacher


  • Open Access

    Epidemiological Comparative Study on Contact Sensitisations in Woodworkers With Occupational Dermatitis: Patch Test Data of the Information Network of Departments of Dermatology, 1999 to 2023

    by Luisa Heizmann, Steffen Schubert, Andrea Bauer, Detlef Becker, Knut Brockow, Heinrich Dickel, Birger Kränke, Claudia Lang, Eva Oppel, Nicola Wagner, et al.

    Background: Woodworkers (WW) are exposed to a wide range of occupational hazards and potent allergens. Objectives: To describe the contact sensitisation pattern of WW with occupational dermatitis (OD). Methods: In a retrospective study, patch test and clinical data collected by the Network of Departments of Dermatology (IVDK) from 1999 to 2023 were analysed. Data of 471 WW with OD (89.6% male) were compared with data of 558 WW without OD and 39 759 patients from other occupational groups (non‐WW) with OD. Results: Allergic contact dermatitis (32.5%) was the most frequent diagnosis among WW with OD. Hands (63.5%) were predominantly involved. Face dermatitis (8.5%) and dust exposure (36.6%) as contributing factors were significantly more common than in non‐WW with OD. Sensitisations to epoxy resin (5.5%) were significantly more frequent in male WW with OD than in male WW without OD. Other frequent sensitisations included those to Myroxylon pereirae (7.4%), propolis (5.6%), and colophonium (5.3%). Sensitisations to chromium, cobalt, thiuram mix, fragrance mix II and compositae mix II were significantly less frequent than in male non‐WW patients with OD. Conclusions: Allergic contact dermatitis is frequent in WW with OD. Important allergens include resins and plant‐derived substances. Airborne OD may interfere with prevention efforts.


  • Open Access

    Contact Allergy in Children in Europe: A Proposal for a Paediatric European Baseline Series

    by Anne Birgitte Simonsen, Thomas Rustemeyer, Suzana Ljubojevicé Hadzavdic, Radoslaw Spiewak, Anna Belloni Fortina, Margarida Gonçalo, Ana Maria Giménez Arnau, Nidia Planella‐Fontanillas, Marie L. A. Schuttelaar, Heinrich Dickel, et al.

    Background: Contact allergy is common in children, but no paediatric baseline series ( pEBS ) exists in Europe, despite recommendations in several countries. Objectives: To collect and compare patch testing data from European centres to propose a common pEBS , possibly adapted by age group. Materials and Methods: Data from 13 centres in 12 European countries were aggregated, covering 1816 children (1099 girls, 60.5%), aged 0–16 years, tested with the adult EBS ( aEBS ) and other frequent allergens between 2018 and 2022. Allergen selection followed adult criteria, with a stricter cut‐off for inclusion, requiring at least 1% positive reactions (lower 95% CI ) in children. Results: A total of 17 allergens from the aEBS caused positive reactions in ≥ 1% of children (lower 95% CI ). Common allergens included metals, fragrances, and preservatives. Tixocortol‐21‐pivalate was included despite its lower frequency due to its difficult‐to‐suspect nature. Additional frequent allergens were hydroperoxides of limonene and linalool, Amerchol L‐101, and sorbitan sesquioleate. In total, 18 allergens were identified as potentially qualifying for a pEBS , with a further 7 as recommended additions. Conclusion: Results from patch testing children across europe highlight a common set of frequent allergens, which should be considered for a pEBS.


  • Variability in Paediatric Patch Test Practices Across Europe: A Survey From the European Baseline Series (EBS) Working Party on Behalf of the European Society of Contact Dermatitis (ESCD)

    by Olivier Aerts, Thomas Rustemeyer, Anna Belloni‐Fortina, Sonia Badulici, Heinrich Dickel, Jose Luis Garcia Abujeta, Ana Maria Giménez‐Arnau, Margarida Gonçalo, Catherine R. Holden, Marléne Isaksson, et al.

    Background: Allergic contact dermatitis (ACD) is an increasingly recognised condition in children and adolescents. However, there is limited knowledge about the different paediatric patch test procedures in European patch test clinics.Objectives: To map current European paediatric patch test practices, and to relate these to the existing literature, with the aim of guiding the development of a future paediatric patch test guideline, and a corresponding paediatric European baseline series (pEBS).Materials and Methods: In the course of late 2023/early 2024, a standardised paediatric patch test e‐mail questionnaire was developed, distributed, and discussed among members of the European Baseline Series (EBS) Working Party of the European Society of Contact Dermatitis (ESCD).Results: Areas of agreement and discussion were identified regarding patch testing in children of different ages, with and without atopic dermatitis: (contra)indications, choice of allergens and patch test chambers, peculiarities regarding the application and fixation of tests, occlusion and reading times.Conclusion: Although variability exists in paediatric patch test practices across Europe, there is broad agreement on common procedures, and only a few areas of debate; these findings may be used to inform the development of a future paediatric patch test guideline and pEBS.


  • Open Access

    Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life

    by Henriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, Detlef Becker, Philipp Bentz, Richard Brans, Tricia Chong, Heinrich Dickel, Peter Elsner, Ana M. Giménez‐Arnau, et al.

    Background: Hand eczema (HE) is a common and complex skin disease. A uniform set of core outcomes and related measures for use in clinical trials is lacking, making it difficult to compare results across HE studies.Objective: To reach consensus on a set of core domains and subdomains that should be measured in future therapeutic HE trials.Methods: In 2024, we conducted a two‐round online Delphi (eDelphi) survey among international HE experts, including physicians, patients and their relatives, researchers and industry representatives. A domain/subdomain was included in the core set when ≥80% of participants rated is as ‘critically important’; 50% agreement or less resulted in its exclusion. Results from 50% to 80% were deemed controversial and subject for further discussion. During a hybrid consensus meeting, the stakeholders reviewed, completed and, if necessary, revised the preliminary eDelphi consensus.Results: In the first and second round of the eDelphi, 208 and 134 persons, respectively, participated. Forty participants from 18 countries attended the consensus meeting. Consensus was reached to include the core domains ‘signs of HE’ (with five core subdomains), ‘symptoms of HE’ (two subdomains), ‘HE‐related quality of life’ (four subdomains) and ‘HE control over time’ (four subdomains). The subdomains ‘desquamation/scaling’ and ‘emotional impact/mental health’ remained controversial. Consensus was reached that the domains ‘skin barrier function’ and ‘patient‐reported treatment experience’ and 28 subdomains should not be part of the core outcome set.Conclusions: To produce comparable and meaningful results, future trials evaluating the effectiveness of HE treatments should measure signs and symptoms of HE, HE‐related quality of life and HE control over time as core outcome domains. The next step of the HE core outcome set initiative (HECOS) is to identify appropriate measurement instruments.


  • Open Access

    Severely compromised supply of patch test allergens in Europe hampers adequate diagnosis of occupational and non‐occupational contact allergy. A European Society of Contact Dermatitis (ESCD), European Academy of Allergy and Clinical Immunology (EAACI), European Academy of Dermatology and Venereology (EADV) task forces ‘Contact Dermatitis’ and ‘Occupational Skin Disease’ position paper

    by Swen Malte John, Andreas Bonertz, Julia Zimmer, Olivier Aerts, Andrea Bauer, Maria Bova, Richard Brans, Stefano Del Giacco, Heinrich Dickel, Monica Corazza, et al.

    Patch testing is the only clinically applicable diagnostic method for Type IV allergy. The availability of Type IV patch test (PT) allergens in Europe, however, is currently scarce. This severely compromises adequate diagnostics of contact allergy, leading to serious consequences for the affected patients. Against this background, the European Society of Contact Dermatitis (ESCD) has created a task force (TF) (i) to explore the current availability of PT substances in different member states, (ii) to highlight some of the unique characteristics of Type IV vs. other allergens and (iii) to suggest ways forward to promote and ensure availability of high‐quality patch testing substances for the diagnosis of Type IV allergies throughout Europe. The suggestions of the TF on how to improve the availability of PT allergens are supported by the ESCD, the European Academy of Allergy and Clinical Immunology, and the European Academy of Dermatology and Venereology and intend to provide potential means to resolve the present medical crisis.


  • Open Access

    S2k‐Leitlinie Diagnostik, Prävention und Therapie des Handekzems

    by Andrea Bauer, Richard Brans, Randolf Brehler, Marion Büttner, Heinrich Dickel, Peter Elsner, Manigé Fartasch, Claudia Herzog, Swen‐Malte John, Arno Köllner, et al.